Literature DB >> 11510796

European Respiratory Society Guidelines on the use of nebulizers.

J Boe1, J H Dennis, B R O'Driscoll, T T Bauer, M Carone, B Dautzenberg, P Diot, K Heslop, L Lannefors.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11510796     DOI： 10.1183/09031936.01.00220001

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  43 in total

Review 1.  [Diagnosis and therapy of COPD exacerbation].

Authors:  T T Bauer; G Nilius; W Grüning; K Rasche
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04-04       Impact factor: 0.840

2.  Nebulizer therapy in cystic fibrosis: an overview.

Authors:  Nicola Collins
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

Review 3.  Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.

Authors:  Worth Longest; Benjamin Spence; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-07-09       Impact factor: 2.849

4.  Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Authors:  Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-15

5.  A modified nebulization modality versus classical ultrasonic nebulization and oxygen-driven nebulization in facilitating airway clearance in patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Qiaoling Luo; Zeguang Zheng; Huihong Cen; Mei Jiang; Qin Chen
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

6.  Identification and validation of nebulized aerosol devices for sputum induction.

Authors:  Warren J Davidson; John Dennis; Stephanie The; Belinda Litoski; Cora Pieron; Richard Leigh
Journal:  Can Respir J       Date:  2013-11-28       Impact factor: 2.409

7.  Aerosolized Delivery of Antifungal Agents.

Authors:  Jennifer Le; Daryl S Schiller
Journal:  Curr Fungal Infect Rep       Date:  2010-04-13

8.  Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation.

Authors:  Syed H R Mazhar; Nahlah E Ismail; Duncan A G Newton; Henry Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2007-10-08       Impact factor: 4.335

9.  Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis.

Authors:  Tacjana Pressler
Journal:  Biologics       Date:  2008-12

10.  Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance.

Authors:  Giovanni Invernizzi; Ario Ruprecht; Cinzia De Marco; Roberto Mazza; Gabriele Nicolini; Roberto Boffi
Journal:  Respir Res       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.